Q-omics provides the consensus-scored RNA5-8SN1 profile across patient tissues and cancer cell-line models. RNA5-8SN1 expression is associated with patient survival in 5 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, RNA5-8SN1 is differentially expressed in 1, with the highest sampling consensus in LUAD. Additionally, RNA5-8SN1 RNA expression shows 3,777 significant gene co-expression associations, with the highest sampling consensus in BRCA. Together, these results highlight BLCA, LUAD, and BRCA as cancer lineages where RNA5-8SN1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RNA5-8SN1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RNA5-8SN1 survival associations across molecular data types. RNA5-8SN1 RNA expression shows survival associations in the most cancer types (5). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RNA5-8SN1 RNA expression–survival associations across cancer types. High RNA5-8SN1 expression shows unfavorable associations in BLCA, LUAD, KIRC and OV, but favorable associations in LAML. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for RNA5-8SN1 RNA expression.
This table summarizes RNA5-8SN1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in LUAD for RNA.
This table ranks reproducible tumor–normal expression differences for RNA5-8SN1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RNA5-8SN1 shows higher tumor expression in LUAD. The LUAD box plot shows higher RNA5-8SN1 RNA expression in tumor versus normal tissue (log2 FC = +0.146, t-test p = .042).
This table shows molecular features associated with RNA5-8SN1 in patient tissues and cancer cell lines. In patient samples, RNA5-8SN1 shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set.
